Stay updated on Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record for the Phase 2 andecaliximab-plus-nivolumab trial is displayed with its study details, results, eligibility criteria, participating locations, and supporting documents.
    Difference
    62%
    Check dated 2026-11-07T12:35:14.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T13:17:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website transition updates and notes that some content may use “Super Intelligence” instead of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T17:42:31.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T17:14:02.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T18:14:25.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous study details. This indicates that access to the content is currently blocked.
    Difference
    18%
    Check dated 2026-09-19T19:22:15.000Z thumbnail image

Stay in the know with updates to Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.